Isbister Geoffrey K, Graudins Andis, White Julian, Warrell David
Discipline of Clinical Pharmacology, University of Newcastle and Newcastle Mater Misericordiae Hospital, Newcastle, NSW, Australia.
J Toxicol Clin Toxicol. 2003;41(3):291-300. doi: 10.1081/clt-120021114.
Envenomation by arachnids causes significant medical illness worldwide. Scorpion sting is the most important arachnid envenomation causing adult morbidity and pediatric mortality. Important groups of spiders include the widow spiders (Latrodectus spp.), the recluse spiders (Loxosceles spp.), and two spiders confined to single countries: the Australian funnel web spider (Atrax and Hadronyche spp.) and the armed spider (Phoneutria spp.) from Brazil. There are four widow spider antivenoms available, including the Australian redback spider antivenom and the American black widow antivenom. Despite good in vitro animal work demonstrating effective neutralization with these antivenoms, and cross-reactivity between many species, there continues to be a reluctance to use them in some countries. They are both associated with a relatively low rate of allergic reactions. Redback antivenom is routinely used by the intramuscular route, which may not be as effective as intravenous use based on clinical experience and animal studies. Antivenoms are available for Loxosceles spp., but there is little evidence to support their effectiveness, particularly against local effects. The Australian funnel web spider causes severe neurotoxic envenomation, and antivenom appears to be effective in reported cases. An antivenom exists for the Brazilian armed spider, but is used in only a minority of cases. Many scorpion antivenoms exist worldwide, but there remains significant controversy regarding their efficacy. Animal and human venom level studies demonstrate neutralization of circulating venom in systemic envenomation. Clinical experience in countries where antivenom has been introduced suggests it has reduced pediatric mortality. However, three controlled trials demonstrated that antivenom was not effective, but these included few severe cases. Until controlled trials of antivenom in systemically envenomated patients are undertaken, antivenom use appears justified in severe envenomation. Although envenomation from arthropods is common, no antivenoms exist for these, excepting Lonomia caterpillars in South America, and Ixodes paralysis ticks in Australia.
蛛形纲动物的毒液在全球范围内引发严重的医学疾病。蝎子蜇伤是最重要的蛛形纲动物毒液中毒情况,可导致成人发病和儿童死亡。重要的蜘蛛种类包括寡妇蜘蛛(Latrodectus属)、隐居蜘蛛(Loxosceles属),以及仅分布于单个国家的两种蜘蛛:澳大利亚漏斗网蜘蛛(Atrax和Hadronyche属)和巴西的武装蜘蛛(Phoneutria属)。有四种针对寡妇蜘蛛的抗蛇毒血清,包括澳大利亚红背蜘蛛抗蛇毒血清和美国黑寡妇抗蛇毒血清。尽管在体外动物实验中显示这些抗蛇毒血清能有效中和毒液,且许多物种之间存在交叉反应,但在一些国家仍不愿使用它们。这两种抗蛇毒血清引发过敏反应的几率都相对较低。红背蜘蛛抗蛇毒血清通常通过肌肉注射途径使用,根据临床经验和动物研究,其效果可能不如静脉注射。有针对Loxosceles属蜘蛛的抗蛇毒血清,但几乎没有证据支持其有效性,尤其是对局部影响方面。澳大利亚漏斗网蜘蛛会导致严重的神经毒性毒液中毒,在已报道的病例中抗蛇毒血清似乎有效。有一种针对巴西武装蜘蛛的抗蛇毒血清,但仅在少数病例中使用。全球有许多蝎子抗蛇毒血清,但关于其疗效仍存在重大争议。动物和人体毒液水平研究表明,在全身性毒液中毒中抗蛇毒血清可中和循环中的毒液。在引入抗蛇毒血清的国家的临床经验表明,它降低了儿童死亡率。然而,三项对照试验表明抗蛇毒血清无效,但这些试验中严重病例较少。在对全身性毒液中毒患者进行抗蛇毒血清对照试验之前,在严重毒液中毒情况下使用抗蛇毒血清似乎是合理的。尽管节肢动物的毒液中毒很常见,但除了南美洲的洛诺米毛虫和澳大利亚的硬蜱麻痹蜱外,针对这些动物没有抗蛇毒血清。